160 related articles for article (PubMed ID: 32212270)
1. Ocular toxoplasmosis in a patient treated with ustekinumab for psoriasis.
Javadzadeh S; Gkini MA; Panos GD; Adewoyin T; Bewley A
Clin Exp Dermatol; 2020 Aug; 45(6):802-804. PubMed ID: 32212270
[No Abstract] [Full Text] [Related]
2. Post-prophylaxis Toxoplasma chorioretinitis following donor-recipient mismatched liver transplantation.
Webb GJ; Shah H; David MD; Tiew S; Beare N; Hirschfield GM
Transpl Infect Dis; 2016 Oct; 18(5):805-808. PubMed ID: 27500398
[TBL] [Abstract][Full Text] [Related]
3. Treatment of psoriasis with ustekinumab in a patient with HIV-related Kaposi sarcoma.
Wang DM; Fernandez AP; Calabrese CM; Calabrese LH
Clin Exp Dermatol; 2019 Jan; 44(1):113-115. PubMed ID: 29797733
[No Abstract] [Full Text] [Related]
4. Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis.
Fioranelli M; Roccia MG; Lotti T
Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28508536
[No Abstract] [Full Text] [Related]
5. [Bilateral toxoplasma retinochoroiditis secondary to primary infection in an immunocompetent patient].
Rémond AL; Diwo E; Zarrouk V; Bodaghi B
J Fr Ophtalmol; 2018 Oct; 41(8):e361-e366. PubMed ID: 30253870
[No Abstract] [Full Text] [Related]
6. Severe Small-Vessel Vasculitis Temporally Associated With Administration of Ustekinumab.
MacArthur KM; Merkel PA; Van Voorhees AS; Nguyen J; Rosenbach M
J Drugs Dermatol; 2016 Mar; 15(3):359-62. PubMed ID: 26954323
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
[No Abstract] [Full Text] [Related]
8. Psoriasis vulgaris complicated by eosinophilic pneumonia during ustekinumab treatment.
Yashiro M; Maejima H; Taniguchi T; Katsuoka K; Kimura M; Wada M
Eur J Dermatol; 2013; 23(3):396-7. PubMed ID: 23728153
[No Abstract] [Full Text] [Related]
9. Inverse psoriasis treated with ustekinumab.
Campos MA; Varela P; Baptista A; Moreira AI
BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27222277
[TBL] [Abstract][Full Text] [Related]
10. Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?
Gkini MA; Bewley AP
Dermatol Ther; 2018 Nov; 31(6):e12742. PubMed ID: 30221819
[No Abstract] [Full Text] [Related]
11. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
Onsun N; Yalcin B; Sallahoglu K; Rezvani A
Am J Ther; 2018; 25(3):e381-e382. PubMed ID: 29189317
[No Abstract] [Full Text] [Related]
12. Safety of ustekinumab for the treatment of psoriasis vulgaris with myotonic dystrophy.
Fujita Y; Shinkuma S; Nomura T; Shimizu H
Eur J Dermatol; 2016 Apr; 26(2):187-8. PubMed ID: 26643260
[No Abstract] [Full Text] [Related]
13. Safety of ustekinumab in severe psoriasis with chronic hepatitis B.
Raymundo AR; Facin AP; Silva de Castro CC; Faria AR
Indian J Dermatol Venereol Leprol; 2016; 82(3):326-8. PubMed ID: 27088944
[No Abstract] [Full Text] [Related]
14. Thrombocytopenia in a psoriatic patient sequentially treated with adalimumab, secukinumab and ustekinumab.
Nakahara T; Konishi S; Yasukochi Y; Esaki H; Tsuji G; Kido-Nakahara M; Furue M
J Dermatol; 2019 May; 46(5):e157-e158. PubMed ID: 30353917
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period.
Megna M; Napolitano M; Balato N; Monfrecola G; Villani A; Ayala F; Balato A
Clin Exp Dermatol; 2016 Jul; 41(5):564-6. PubMed ID: 27028505
[No Abstract] [Full Text] [Related]
16. Ocular toxoplasmosis: toxoplasmic retinochoroiditis.
Tabbara KF
Int Ophthalmol Clin; 1995; 35(2):15-29. PubMed ID: 7490177
[No Abstract] [Full Text] [Related]
17. Intracranial hypertension syndrome in a patient with psoriasis receiving ustekinumab.
Reyes Bueno JA; Reyes Garrido V; León A; Bustamante R
Neurologia (Engl Ed); 2019 May; 34(4):281-282. PubMed ID: 28712842
[No Abstract] [Full Text] [Related]
18. An analysis of Drug Survival, Effectiveness, and Safety in Moderate to Severe Psoriasis Treated With Ustekinumab: An Observational Study of 69 Patients in Routine Clinical Practice.
Salgüero Fernández I; Gil MH; Sanz MS; Gullón GR
Actas Dermosifiliogr (Engl Ed); 2019 Apr; 110(3):244-246. PubMed ID: 29961546
[No Abstract] [Full Text] [Related]
19. Long-term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma.
Gkalpakiotis S; Arenberger P; Fridman M; Arenbergerova M
Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28730674
[No Abstract] [Full Text] [Related]
20. Use of ustekinumab in five psoriatic patients with hepatitis B virus infection.
Piaserico S; Conti A; Coati I; Galdo G; Bernabucci V; Zanca A; Drabeni M; Masutti F; Musumeci ML; Alberti A; Russo FP
G Ital Dermatol Venereol; 2019 Jun; 154(3):376-377. PubMed ID: 28712266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
